National Strategy For Biomedical Innovation Simmering On Hamburg’s Agenda
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA commissioner says all stakeholders need to come to the table to develop a path for maintaining U.S. preeminence in making medical discoveries and moving them through the pharmaceutical pipeline into patients’ hands.